Molecular Imaging for Theranostics

We develop novel imaging probes for diagnosis and treatment of various diseases at the molecular level.
By manipulating biomacromolecules such as monoclonal antibodies and oligonucleotides, our long-term goal is to devise effective theranostics with optimal specificity and minimum toxicity for cancer, kidney injury, and central nervous system disorders.